Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-30 Sale | 2024-10-02 4:37 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,000 | $29.03 | $870,900 | 840,893 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:15 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,727 | $23.79 | $41,085 | 870,893 (Indirect Direct) | View |
| 2024-06-13 Sale | 2024-07-03 9:13 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,688 | $22.11 | $678,660 | 872,620 (Indirect Direct) | View |
| 2024-04-01 Sale | 2024-04-02 6:07 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 92,500 | $20.5 | $1,896,250 | 897,341 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:16 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,750 | $17.29 | $47,548 | 989,841 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:34 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 3,208 | $19.43 | $62,331 | 992,591 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:31 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,419 | $22.6 | $32,069 | 995,799 (Indirect Direct) | View |
| 2023-02-13 Sale | 2023-02-15 7:02 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,119 | $30.1 | $63,782 | 993,002 (Indirect Direct) | View |
| 2023-02-08 Sale | 2023-02-10 6:10 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,377 | $30.88 | $42,522 | 995,121 (Indirect Direct) | View |
| 2023-01-05 Sale | 2023-01-09 9:42 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,970 | $28.44 | $84,467 | 996,498 (Indirect Direct) | View |
| 2022-08-19 Sale | 2022-08-23 4:47 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,253 | $33.22 | $74,845 | 999,468 (Indirect Direct) | View |
| 2022-02-11 Sale | 2022-02-15 6:56 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 2,560 | $34.69 | $88,806 | 970,221 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-31 Exercise | 2024-11-04 5:28 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 12,997 (Direct) | View |
| 2024-09-30 Exercise | 2024-10-01 5:58 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 12,997 (Direct) | View |
| 2024-08-31 Exercise | 2024-09-03 4:43 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 155 | $0 | 12,997 (Direct) | View |
| 2024-07-31 Exercise | 2024-08-01 6:46 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 12,997 (Direct) | View |
| 2024-06-30 Exercise | 2024-07-02 4:49 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 12,997 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 7:57 pm | N/A 2034-06-13 | PLIANT THERAPEUTICS INC. | PLRX | Krognes Steve E. Director | 53,528 | $0 | 53,528 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-13 8:56 pm | N/A 2034-06-12 | Guardant Health Inc. | GH | Krognes Steve E. Director | 17,377 | $0 | 26,517 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-13 8:56 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 5,592 | $0 | 26,517 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:33 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 23,868 | $0 | 921,209 (Direct) | View |
| 2024-05-31 Exercise | 2024-06-03 6:20 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 155 | $0 | 7,405 (Direct) | View |
| 2024-04-30 Exercise | 2024-05-02 5:03 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-01 5:25 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 5:08 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-01 5:38 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 155 | $0 | 7,405 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-02 6:06 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-11-30 Exercise | 2023-12-04 6:22 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-01 8:07 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-02 5:14 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 155 | $0 | 7,405 (Direct) | View |
| 2023-08-31 Exercise | 2023-09-05 4:46 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-07-31 Exercise | 2023-08-01 6:08 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-05 4:59 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 1,851 | $0 | 7,405 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:48 pm | N/A 2033-06-15 | Gritstone bio Inc. | GRTS | Krognes Steve E. Director | 51,800 | $0 | 51,800 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 6:10 pm | N/A 2033-06-14 | Guardant Health Inc. | GH | Krognes Steve E. Director | 14,395 | $0 | 14,395 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 6:07 pm | N/A 2033-06-01 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 16,865 | $0 | 1,009,867 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-11 4:12 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 19,284 | $0 | 19,284 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 7:36 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 62,500 | $0.68 | 1,001,721 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 7:36 pm | 2022-07-19 2022-08-01 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 62,500 | $0 | 1,001,721 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 5:34 pm | N/A 2032-06-16 | Gritstone bio Inc. | GRTS | Krognes Steve E. Director | 19,000 | $0 | 19,000 (Direct) | View |